あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/23 | 2,367 | 2,370 | 2,340 | 2,350 | +7 | +0.3% | 16,000 |
2025/05/22 | 2,304 | 2,365 | 2,303 | 2,343 | +12 | +0.5% | 29,400 |
2025/05/21 | 2,335 | 2,367 | 2,327 | 2,331 | -4 | -0.2% | 27,500 |
2025/05/20 | 2,350 | 2,377 | 2,301 | 2,335 | -16 | -0.7% | 49,200 |
2025/05/19 | 2,373 | 2,374 | 2,330 | 2,351 | -22 | -0.9% | 53,200 |
2025/05/16 | 2,544 | 2,544 | 2,373 | 2,373 | +79 | +3.4% | 91,300 |
2025/05/15 | 2,260 | 2,297 | 2,260 | 2,294 | +39 | +1.7% | 45,200 |
2025/05/14 | 2,254 | 2,283 | 2,228 | 2,255 | +1 | ±0% | 35,800 |
2025/05/13 | 2,216 | 2,300 | 2,170 | 2,254 | -62 | -2.7% | 65,900 |
2025/05/12 | 2,317 | 2,329 | 2,298 | 2,316 | -10 | -0.4% | 40,400 |
2025/05/09 | 2,317 | 2,401 | 2,234 | 2,326 | +9 | +0.4% | 110,800 |
2025/05/08 | 2,327 | 2,353 | 2,289 | 2,317 | +11 | +0.5% | 52,400 |
2025/05/07 | 2,261 | 2,359 | 2,261 | 2,306 | +10 | +0.4% | 94,400 |
2025/05/02 | 2,300 | 2,314 | 2,287 | 2,296 | -4 | -0.2% | 34,800 |
2025/05/01 | 2,324 | 2,324 | 2,299 | 2,300 | -24 | -1% | 21,600 |
2025/04/30 | 2,334 | 2,345 | 2,303 | 2,324 | +7 | +0.3% | 35,900 |
2025/04/28 | 2,330 | 2,330 | 2,293 | 2,317 | +17 | +0.7% | 134,000 |
2025/04/25 | 2,345 | 2,345 | 2,289 | 2,300 | -4 | -0.2% | 26,800 |
2025/04/24 | 2,260 | 2,314 | 2,229 | 2,304 | -77 | -3.2% | 103,000 |
2025/04/23 | 2,397 | 2,400 | 2,365 | 2,381 | -12 | -0.5% | 24,800 |
2025/04/22 | 2,387 | 2,412 | 2,373 | 2,393 | +39 | +1.7% | 49,300 |
2025/04/21 | 2,378 | 2,393 | 2,352 | 2,354 | -22 | -0.9% | 31,300 |
2025/04/18 | 2,304 | 2,376 | 2,302 | 2,376 | +78 | +3.4% | 29,700 |
2025/04/17 | 2,264 | 2,308 | 2,264 | 2,298 | +9 | +0.4% | 16,600 |
2025/04/16 | 2,296 | 2,307 | 2,288 | 2,289 | -7 | -0.3% | 27,200 |
2025/04/15 | 2,300 | 2,306 | 2,288 | 2,296 | -2 | -0.1% | 22,900 |
2025/04/14 | 2,281 | 2,306 | 2,276 | 2,298 | +52 | +2.3% | 22,900 |
2025/04/11 | 2,224 | 2,251 | 2,199 | 2,246 | -28 | -1.2% | 45,500 |
2025/04/10 | 2,270 | 2,299 | 2,252 | 2,274 | +142 | +6.7% | 49,600 |
2025/04/09 | 2,119 | 2,151 | 2,106 | 2,132 | -37 | -1.7% | 52,300 |
2025/04/08 | 2,143 | 2,196 | 2,136 | 2,169 | +76 | +3.6% | 46,900 |
2025/04/07 | 2,068 | 2,140 | 2,068 | 2,093 | -125 | -5.6% | 94,500 |
2025/04/04 | 2,234 | 2,262 | 2,187 | 2,218 | -66 | -2.9% | 73,800 |
2025/04/03 | 2,203 | 2,293 | 2,203 | 2,284 | -16 | -0.7% | 57,200 |
2025/04/02 | 2,310 | 2,315 | 2,272 | 2,300 | -20 | -0.9% | 46,600 |
2025/04/01 | 2,313 | 2,341 | 2,312 | 2,320 | +16 | +0.7% | 34,000 |
2025/03/31 | 2,300 | 2,317 | 2,290 | 2,304 | -6 | -0.3% | 46,200 |
2025/03/28 | 2,301 | 2,322 | 2,290 | 2,310 | -32 | -1.4% | 52,900 |
2025/03/27 | 2,324 | 2,344 | 2,314 | 2,342 | +18 | +0.8% | 40,700 |
2025/03/26 | 2,307 | 2,329 | 2,283 | 2,324 | -6 | -0.3% | 57,100 |
2025/03/25 | 2,300 | 2,331 | 2,300 | 2,330 | +30 | +1.3% | 16,400 |
2025/03/24 | 2,307 | 2,317 | 2,292 | 2,300 | -7 | -0.3% | 26,800 |
2025/03/21 | 2,300 | 2,311 | 2,292 | 2,307 | +7 | +0.3% | 30,300 |
2025/03/19 | 2,277 | 2,323 | 2,256 | 2,300 | +6 | +0.3% | 67,900 |
2025/03/18 | 2,317 | 2,325 | 2,294 | 2,294 | -41 | -1.8% | 37,000 |
2025/03/17 | 2,302 | 2,338 | 2,287 | 2,335 | +10 | +0.4% | 46,200 |
2025/03/14 | 2,324 | 2,334 | 2,303 | 2,325 | +8 | +0.3% | 46,100 |
2025/03/13 | 2,300 | 2,320 | 2,298 | 2,317 | +31 | +1.4% | 52,500 |
2025/03/12 | 2,299 | 2,309 | 2,265 | 2,286 | +21 | +0.9% | 58,200 |
2025/03/11 | 2,201 | 2,268 | 2,201 | 2,265 | +51 | +2.3% | 67,100 |
1~
50
件表示中 / 1013件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 235,000円 | +16.9% | +33.2% | 2.34% | 12.82倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 45,100円 | +14.3% | - | 4.43% | 18.32倍 | 1.17倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
タウンズ | 55,200円 | +4.6% | +6.1% | 5.07% | 9.40倍 | 3.48倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム